| Literature DB >> 35267781 |
Meng Zhang1,2, Fengshi Zhang1,2, Ci Li1,2, Heng An3, Teng Wan1,2, Peixun Zhang1,2,4.
Abstract
Chitosan is a biodegradable natural polymer derived from the exoskeleton of crustaceans. Because of its biocompatibility and non-biotoxicity, chitosan is widely used in the fields of medicine and agriculture. With the latest technology and technological progress, different active functional groups can be connected by modification, surface modification, or other configurations with various physical, chemical, and biological properties. These changes can significantly expand the application range and efficacy of chitosan polymers. This paper reviews the different uses of chitosan, such as catheter bridging to repair nerve broken ends, making wound auxiliaries, as tissue engineering repair materials for bone or cartilage, or as carriers for a variety of drugs to expand the volume or slow-release and even show potential in the fight against COVID-19. In addition, it is also discussed that chitosan in agriculture can improve the growth of crops and can be used as an antioxidant coating because its natural antibacterial properties are used alone or in conjunction with a variety of endophytic bacteria and metal ions. Generally speaking, chitosan is a kind of polymer material with excellent development prospects in medicine and agriculture.Entities:
Keywords: agriculture; biomedical; biopolymers; chitosan; chitosan derivative; delivery systems; wound dressing
Year: 2022 PMID: 35267781 PMCID: PMC8912330 DOI: 10.3390/polym14050958
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Preparation of chitosan by deacetylation. Chitosan (B) is formed by deacetylation of chitin (A).
Modification of chitosan and its derivatives and their significant properties.
| Types | Functional Group | Common Derivatives | Applications | Reference |
|---|---|---|---|---|
| Thiolated chitosan derivatives | the thiol groups | chitosan-6-mercaptonicotinic acid; | Tissue-engineered scaffolds; | [ |
| Phosphorylation of chitosan derivatives | phosphate groups | N-methylene phosphonic chitosan | Induced bone formation; | [ |
| Crosslinked chitosan derivatives | cross-linking bridges | Ethylene diamine tetraacetic acid chitosan polymer; | Drug delivery systems; | [ |
| Carboxylic acid chitosan derivatives | Carboxymethyl group | N, O-carboxymethyl chitosan; | Tissue engineering scaffold materials; | [ |
| Cationic chitosan derivatives | quaternary functional groups | N-(2-hydroxy) propyl-3-trimethylammonium chitosan; | Antibacterial activity; | [ |
| Sulfated chitosan derivatives | –SO42− groups | 6-O-sulfated chitosan; | Tissue repair and regeneration; | [ |
Figure 2Phosphorylated chitosan. (A) Reaction of phosphorus pentoxide and chitosan to obtain highly substituted and water-soluble phosphorylated chitosan. (B) Preparation of phosphorylated chitosan by graft copolymerization of mono(2-methacryloyloxyethyl) phosphate chitosan.
Figure 3Direct quaternization of chitosan. (A) Processing of chitosan by haloalkanes under alkaline conditions. (B) Chitosan is first reacted with aldehyde, further reduced by sodium borohydride or sodium cyanoborohydride, and finally reacted with haloalkanes to obtain quaternized chitosan.
Figure 4Indirect quaternization of chitosan. Introduction of small molecules containing quaternary ammonium groups into chitosan. (A) (5-bromopentyl)trimethylammonium bromide. (B) trimethylammonium chloride of glycidyl ester. (C) Preparation of quaternized chitosan by reaction of chitosan 3-chloro-2-hydroxypropyltrimethylammonium chloride.
Figure 5Anti-tumor effects of chitosan and its derivatives. (A) Chitosan induces apoptosis in tumor cells. (B) Carboxymethyl chitosan promotes the secretion of TNF-α and IL-1 cytokines and enhances macrophage phagocytosis. (C) Chitosan inhibits cancer cell metastasis by inhibiting MMP.
Figure 6Other biomedical applications of chitosan. (A) Chitosan promotes wound healing. (B) Chitosan as a bone and cartilage tissue engineering repair material. (C) PH-sensitive chitosan drug delivery system. (D) The role of chitosan in the protection against SARS-CoV-2.
Chitosan-based nanocarriers and their mechanism.
| Nanocarrier Component | Loaded Drug | Vivo or Vitro | Efficacy Mechanism | Reference |
|---|---|---|---|---|
| Chitosan nanocarrier | Gemcitabine | In vitro | Oral adsorption | [ |
| Chitosan/poly(ethylene glycol) | Gemcitabine | In vitro and in vivo | Reduce the burden of frequent dosing and higher toxicity | [ |
| Chitosan nanoparticle | Herceptin (HER2)conjugated gemcitabine | In vitro | Eventual uptake and prolonged intracellular retention | [ |
| O-carboxymethyl chitosan | Curcumin | In vitro | Increase drug solubility | [ |
| N-octyl-O-sulfate chitosan micelles | Paclitaxel | In vitro | Solubilization of hydrophobic drugs | [ |
| Glycol chitosan–5βcholanic acid (HGC) | Camptothecin | In vitro and in vivo | Increase drug stability, solubility and retention | [ |
| Hydroxyapatite chitosan nanocomposite | Celecoxib | In vitro and in vivo | Sustained-release patterns | [ |
Figure 7Application of chitosan in the field of agriculture. (A) Chitosan can be used to prepare stimulation-controlled drug release systems. (B) Chitosan synergizes with metal or endophytic bacteria to achieve antiseptic and inhibit harmful bacteria.